PROVIDER PROFILE · NPI 1457397341

Karen Naleway

PRACTICELABORATORY CORPORATION OF AMERICASee all providers at this practice →

Nurse PractitionerRockford, ILI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$293

Distinct drugs

Brand share

100.0%

Top prescribed drugs

Norethindrone-Ethin. Estradiol13 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$55

Payment records

By payment type

Food and Beverage$55

Top paying entities

Food and Beverage$55

REFERRAL NETWORK

Where Karen Naleway's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CRUSADERS CENTRAL CLINIC ASSOCIATION	24	147

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
SWEDISHAMERICAN HOSPITAL	31	269
CRUSADERS CENTRAL CLINIC ASSOCIATION	13	78
CRUSADERS CENTRAL CLINIC ASSOCIATION	12	105

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history